24Business
FDA is approved by non-oioid painkillers, Vertex’s Journavx (Suzetrigine)

Vertex’s new Loartavx (Suztrigina) drug is appreciated as a scientific breakthrough because it relieves pain without entering the brain, a minimizing risk of addiction and addictions that patients can increase doses to dangerous levels.
The kindness of the business wire